FindTrial
Sign In

Role of Immunoglobulin G (IgG) in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma

Role of Immunoglobulin G (IgG) in oral submucous fibrosis and oral squamous cell carcinoma - an ex vivo study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/10/058282
Enrollment
36
Registered
2023-10-04
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C069- Malignant neoplasm of mouth, unspecified

Interventions

None listed

Sponsors

Sardar Patel Postgradute Institute of Dental and medical sciences
Lead Sponsor
Dr Pallavi Khare
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.clinically confirmed cases of OSMF 2.histologically confirmed cases of OSCC 3.Healthy volunteers having no oral lesion and not having the habit of tobacco or alcohol uses

Exclusion criteria

Exclusion criteria: 1.Patients receiving radiotherapy or chemotherapy 2.Patients under medications such as immunomodulators or immunosuppressors 3.Patients with bleeding disorders 4.Patients below the age group of 18 years 5.Patients suffering from autoimmune diseases 6.Physiological conditions such as pregnancy.

Design outcomes

Primary

MeasureTime frame
The possible outcome will be to know Corelation of serum IgG levels in clinically confirmed cases of OSMF & histologically confirmed cases of OSCC.Timepoint: 1 day—

Secondary

MeasureTime frame
IgG plays an important roles in OSMF & OSCC, may serve as a potential therapeutic target.Timepoint: 3 months—

Countries

India

Contacts

Public ContactDr. Pallavi Khare

Sardar Patel Post Graduate Institute of Dental and Medical Sciences

aanchee21@gmail.com9559596291

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026